Androgens and Subclinical Atherosclerosis in Young Women - Ancillary to CARDIA
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To examine whether serum androgens, measured earlier in life, and variation in genes related to androgen synthesis, metabolism, and signaling are associated with early-onset subclinical coronary atherosclerosis in young adult women from the community.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2001
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2001
CompletedFirst Submitted
Initial submission to the registry
May 16, 2002
CompletedFirst Posted
Study publicly available on registry
May 17, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedFebruary 10, 2016
December 1, 2005
May 16, 2002
February 8, 2016
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
David Siscovick
University of Washington
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 16, 2002
First Posted
May 17, 2002
Study Start
September 1, 2001
Study Completion
July 1, 2005
Last Updated
February 10, 2016
Record last verified: 2005-12